Annual and Seasonal Surface Circulation Over the Mid-Atlantic Bight Continental Shelf Derived From a Decade of High Frequency Radar Observations

A decade (2007–2016) of hourly 6-km-resolution maps of the surface currents across the Mid-Atlantic Bight (MAB) generated by a regional-scale High Frequency Radar network are used to reveal new insights into the spatial patterns of the annual and seasonal mean surface flows. Across the 10-year time series, temporal means and interannual and intra-annual variability are used to quantify the variability of spatial surface current patterns. The 10-year annual mean surface flows are weaker and mostly cross-shelf near the coast, increasing in speed and rotating to more alongshore directions near the shelfbreak, and increasing in speed and rotating to flow off-shelf in the southern MAB. The annual mean surface current pattern is relatively stable year to year compared to the hourly variations within a year. The 10-year seasonal means exhibit similar current patterns, with winter and summer more cross-shore while spring and fall transitions are more alongshore. Fall and winter mean speeds are larger and correspond to when mean winds are stronger and cross-shore. Summer mean currents are weakest and correspond to a time when the mean wind opposes the alongshore flow. Again, intra-annual variability is much greater than interannual, with the fall season exhibiting the most interseasonal variability in the surface current patterns. The extreme fall seasons of 2009 and 2011 are related to extremes in the wind and river discharge events caused by different persistent synoptic meteorological conditions, resulting in more or less rapid fall transitions from stratified summer to well-mixed winter conditions

Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients

<p>Abstract</p> <p>Background</p> <p>L1 cell adhesion molecule (CD171) is expressed in many malignant tumors and its expression correlates with unfavourable outcome. It thus represents a target for tumor diagnosis and therapy. An earlier study conducted by our group identified L1 expression levels in primary gastrointestinal stromal tumors (GIST) as a prognostic marker. The aim of the current study was to compare L1 serum levels of GIST patients with those of healthy controls and to determine whether levels of soluble L1 in sera could serve as a prognostic marker.</p> <p>Methods</p> <p>Using a sensitive enzyme-linked immunosorbent assay (ELISA), soluble L1 was measured in sera of 93 GIST patients und 151 healthy controls. Soluble L1 levels were then correlated with clinicopathological data.</p> <p>Results</p> <p>Median levels of soluble L1 were significantly higher (<it>p </it>< 0.001; Mann-Whitney U test) in sera of GIST patients compared to healthy individuals. Median soluble L1 levels were particularly elevated in patients with recurrence and relapse (<it>p </it>< 0.05; Mann Whitney U test).</p> <p>Conclusion</p> <p>These results suggest that high soluble L1 levels predict poor prognosis and may thus be a promising tumor marker that can contribute to individualise therapy.</p

Comparative study of T84 and T84SF human colon carcinoma cells: in vitro and in vivo ultrastructural and functional characterization of cell culture and metastasis

To better understand the relationship between tumor heterogeneity, differentiation, and metastasis, suitable experimental models permitting in vitro and in vivo studies are necessary. A new variant cell line (T84SF) exhibiting an altered phenotype was recently selected from a colon cancer cell line (T84) by repetitive plating on TNF-alpha treated human endothelial cells and subsequent selection for adherent cells. The matched pair of cell lines provides a useful system to investigate the extravasation step of the metastatic cascade. Since analysis of morphological differences can be instructive to the understanding of metastatic potential of tumor cells, we compared the ultrastructural and functional phenotype of T84 and T84SF cells in vitro and in vivo. The reported ultrastructural features evidence differences between the two cell lines; selected cells showed a marked pleomorphism of cell size and nuclei, shape, and greater surface complexity. These morphological differences were also coupled with biochemical data showing a distinct tyrosine phosphorylation-based signaling, an altered localization of beta-catenin, MAPK, and AKT activation, as well as an increased expression in T84SF cells of Bcl-X-L, a major regulator of apoptosis. Therefore, these cell lines represent a step forward in the development of appropriate models in vitro and in vivo to investigate colon cancer progression